William Bonello News Today

Cerus Corporation misses on earnings expectations. Reported EPS is $-0.0532 EPS, expectations were $-0.04.

Jeffrey S. Sherman Appointed Chief Financial OfficerFT. MYERS, FL / ACCESSWIRE / December 5, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services

Wall Street brokerages expect that NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) will report earnings of ($0.20) per share for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for NeoGenomics’ earnings, with the highest EPS estimate coming in at ($0.18) and the lowest estimate coming in at ($0.21). NeoGenomics reported earnings of […]

FT. MYERS, FL / ACCESSWIRE / May 16, 2022 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading provider of cancer-focused genetic testing services and global oncology contract research services

Press release content from Accesswire. The AP news staff was not involved in its creation.

Wall Street brokerages predict that NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) will post earnings per share (EPS) of ($0.19) for the current quarter, according to Zacks. Four analysts have provided estimates for NeoGenomics’ earnings. The lowest EPS estimate is ($0.22) and the highest is ($0.17). NeoGenomics reported earnings of ($0.01) per share in the same […]

NeoGenomics (NASDAQ:NEO – Get Rating) released its quarterly earnings results on Wednesday. The medical research company reported ($0.20) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.24) by $0.04, Briefing.com reports. NeoGenomics had a negative net margin of 7.33% and a negative return on equity of 6.62%. The company had revenue of $117.17 […]

NeoGenomics, Inc. (NASDAQ:NASDAQ:NEO) Q1 2022 Earnings Conference Call April 27, 2022, 08:30 AM ET Company Participants Lynn Tetrault - Executive Chair & Principal Executive Officer...

NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) was the recipient of a large decrease in short interest in March. As of March 31st, there was short interest totalling 5,220,000 shares, a decrease of 27.3% from the March 15th total of 7,180,000 shares. Based on an average trading volume of 1,870,000 shares, the short-interest ratio is currently […]

NeoGenomics (NASDAQ:NEO – Get Rating) was upgraded by StockNews.com to a “sell” rating in a research note issued to investors on Saturday. Several other research analysts have also commented on NEO. Zacks Investment Research upgraded shares of NeoGenomics from a “sell” rating to a “hold” rating in a research note on Friday, March 4th. Morgan […]